HK1065032A1 - Piperazine compounds - Google Patents
Piperazine compoundsInfo
- Publication number
- HK1065032A1 HK1065032A1 HK04106467A HK04106467A HK1065032A1 HK 1065032 A1 HK1065032 A1 HK 1065032A1 HK 04106467 A HK04106467 A HK 04106467A HK 04106467 A HK04106467 A HK 04106467A HK 1065032 A1 HK1065032 A1 HK 1065032A1
- Authority
- HK
- Hong Kong
- Prior art keywords
- group
- hydrogen atom
- piperazine compounds
- alkyl group
- rheumatism
- Prior art date
Links
- 150000004885 piperazines Chemical class 0.000 title 1
- 125000000217 alkyl group Chemical group 0.000 abstract 2
- 125000004435 hydrogen atom Chemical group [H]* 0.000 abstract 2
- 206010003210 Arteriosclerosis Diseases 0.000 abstract 1
- 206010020751 Hypersensitivity Diseases 0.000 abstract 1
- 206010061218 Inflammation Diseases 0.000 abstract 1
- 208000026935 allergic disease Diseases 0.000 abstract 1
- 230000007815 allergy Effects 0.000 abstract 1
- 125000004103 aminoalkyl group Chemical group 0.000 abstract 1
- 208000011775 arteriosclerosis disease Diseases 0.000 abstract 1
- 125000003710 aryl alkyl group Chemical group 0.000 abstract 1
- 208000006673 asthma Diseases 0.000 abstract 1
- 125000004181 carboxyalkyl group Chemical group 0.000 abstract 1
- 230000021164 cell adhesion Effects 0.000 abstract 1
- 150000001875 compounds Chemical class 0.000 abstract 1
- GLUUGHFHXGJENI-UHFFFAOYSA-N diethylenediamine Natural products C1CNCCN1 GLUUGHFHXGJENI-UHFFFAOYSA-N 0.000 abstract 1
- 201000010099 disease Diseases 0.000 abstract 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract 1
- 125000004446 heteroarylalkyl group Chemical group 0.000 abstract 1
- 125000002768 hydroxyalkyl group Chemical group 0.000 abstract 1
- 230000008595 infiltration Effects 0.000 abstract 1
- 238000001764 infiltration Methods 0.000 abstract 1
- 230000004054 inflammatory process Effects 0.000 abstract 1
- 230000002401 inhibitory effect Effects 0.000 abstract 1
- -1 piperazine compound Chemical class 0.000 abstract 1
- 230000002265 prevention Effects 0.000 abstract 1
- 150000003839 salts Chemical class 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/496—Non-condensed piperazines containing further heterocyclic rings, e.g. rifampin, thiothixene or sparfloxacin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D213/72—Nitrogen atoms
- C07D213/74—Amino or imino radicals substituted by hydrocarbon or substituted hydrocarbon radicals
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Pulmonology (AREA)
- Epidemiology (AREA)
- Urology & Nephrology (AREA)
- Vascular Medicine (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Pain & Pain Management (AREA)
- Rheumatology (AREA)
- Immunology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Pyridine Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Polymers With Sulfur, Phosphorus Or Metals In The Main Chain (AREA)
- Hydrogenated Pyridines (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US09/893,681 US6432957B1 (en) | 2001-06-29 | 2001-06-29 | Piperazine derivative |
| PCT/JP2002/006491 WO2003002554A1 (fr) | 2001-06-29 | 2002-06-27 | Composes de piperazine |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| HK1065032A1 true HK1065032A1 (en) | 2005-02-08 |
Family
ID=25401910
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| HK04106467A HK1065032A1 (en) | 2001-06-29 | 2004-08-27 | Piperazine compounds |
Country Status (12)
| Country | Link |
|---|---|
| US (1) | US6432957B1 (xx) |
| EP (1) | EP1400521B1 (xx) |
| JP (1) | JP4220897B2 (xx) |
| KR (1) | KR100878416B1 (xx) |
| CN (1) | CN1309720C (xx) |
| AT (1) | ATE377596T1 (xx) |
| CA (1) | CA2451562C (xx) |
| DE (1) | DE60223373T2 (xx) |
| ES (1) | ES2295350T3 (xx) |
| HK (1) | HK1065032A1 (xx) |
| TW (1) | TWI226240B (xx) |
| WO (1) | WO2003002554A1 (xx) |
Families Citing this family (24)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6552188B2 (en) * | 2001-06-29 | 2003-04-22 | Kowa Co., Ltd. | Unsymmetrical cyclic diamine compound |
| US6632810B2 (en) * | 2001-06-29 | 2003-10-14 | Kowa Co., Ltd. | Cyclic diamine compound with condensed-ring groups |
| US6509329B1 (en) * | 2001-06-29 | 2003-01-21 | Kowa Co., Ltd. | Cyclic diamine compound with 6-membered ring groups |
| WO2004032931A1 (ja) * | 2002-10-11 | 2004-04-22 | Kowa Co., Ltd. | 癌の処置方法 |
| AU2003280558A1 (en) * | 2002-10-11 | 2004-05-04 | Kowa Co., Ltd. | Method for treatment of cancer |
| WO2004096810A1 (en) | 2003-04-29 | 2004-11-11 | Pfizer Limited | 5,7-diaminopyrazolo`4,3-d!pyrimidines useful in the treatment of hypertension |
| EP1674100A4 (en) * | 2003-10-10 | 2010-04-14 | Kowa Co | INHIBITOR OF ANGIOGENESIS |
| US7572799B2 (en) * | 2003-11-24 | 2009-08-11 | Pfizer Inc | Pyrazolo[4,3-d]pyrimidines as Phosphodiesterase Inhibitors |
| GB0327323D0 (en) * | 2003-11-24 | 2003-12-31 | Pfizer Ltd | Novel pharmaceuticals |
| US8071626B2 (en) * | 2003-12-18 | 2011-12-06 | Wallac Oy | Chelating agents and highly luminescent and stable chelates and their use |
| EP1577289A1 (en) | 2004-03-18 | 2005-09-21 | Revotar Biopharmaceuticals AG | Non-glycosylated/-glycosidic/-peptidic small molecule selectin inhibitors for the treament of inflammatory disorders |
| DE602005011784D1 (de) * | 2004-04-07 | 2009-01-29 | Pfizer | Pyrazoloä4,3-düpyrimidine |
| DE102004050280B4 (de) | 2004-10-14 | 2009-10-15 | Eukerdruck Gmbh & Co. Kg | Verfahren zur Herstellung eines mehrseitigen Etiketts sowie danach hergestellte mehrseitige Etiketten |
| WO2006082834A1 (ja) * | 2005-02-02 | 2006-08-10 | Kowa Co., Ltd. | ケラチノサイト増殖に起因する疾患の予防・治療剤 |
| EP1764095A1 (en) * | 2005-09-20 | 2007-03-21 | Revotar Biopharmaceuticals AG | Novel nitrocatechol derivatives having selectin ligand activity |
| EP1764093A1 (en) * | 2005-09-20 | 2007-03-21 | Revotar Biopharmaceuticals AG | Novel aromatic compounds and their use in medical applications |
| EP1764096A1 (en) * | 2005-09-20 | 2007-03-21 | Revotar Biopharmaceuticals AG | Novel phloroglucinol derivatives having selectin ligand activity |
| EP1764094A1 (en) * | 2005-09-20 | 2007-03-21 | Revotar Biopharmaceuticals AG | Novel multi-cyclic compounds and their use |
| EP1946756A1 (en) * | 2007-01-17 | 2008-07-23 | Revotar Biopharmaceuticals AG | Use of entacapone in cosmetic, dermatological and pharmaceutical compositions |
| CN102066554B (zh) * | 2008-06-18 | 2016-11-16 | 国立大学法人京都大学 | 细胞粘着促进剂和促进细胞粘着的方法 |
| EP2480890B1 (en) | 2009-09-24 | 2018-02-28 | Anima Biotech Inc. | Methods for measuring translation of target proteins in cells |
| JP7027437B2 (ja) * | 2016-10-27 | 2022-03-01 | エスカリア バイオサイエンシーズ，ビーブイ | ＲＯＲ－γモジュレーター |
| KR20210060367A (ko) | 2018-03-12 | 2021-05-26 | 에스칼리에 바이오사이언시스, 비브이 | 스피로사이클릭 ror-감마 조절제 |
| WO2019177996A1 (en) | 2018-03-12 | 2019-09-19 | Escalier Biosciences B.V. | Bicyclic ror-gamma modulators |
Family Cites Families (17)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB1473262A (en) * | 1974-11-20 | 1977-05-11 | Delalande Sa | Derivatives of n-3,4,5-trimethoxy cinnamoyl-piperazine their process of preparation and their therapeutic application |
| FR2527608B1 (fr) * | 1982-05-28 | 1986-10-10 | Sandoz Sa | Nouveaux composes heterocycliques, leur preparation et leur utilisation comme medicaments |
| US4876256A (en) * | 1988-04-29 | 1989-10-24 | Merck & Co., Inc. | Alkylpiperazinylpyridines as hypoglycemic agents |
| IE911774A1 (en) * | 1990-06-11 | 1991-12-18 | Akzo Nv | Pyridinylpiperazine derivatives |
| US5780472A (en) * | 1995-01-11 | 1998-07-14 | Samjin Pharmaceuticazl Co., Ltd. | Piperazine derivatives and methods for the preparation thereof and compositions containing the same |
| JP3808921B2 (ja) | 1995-11-20 | 2006-08-16 | 興和株式会社 | 細胞接着阻害剤 |
| EP0910384A1 (en) | 1996-04-30 | 1999-04-28 | Hoechst Marion Roussel, Inc. | Method of inhibiting vascular cell adhesion molecule-1 and treating chronic inflammatory diseases with 2,6-di-alkyl-4-silyl-phenols |
| AU2446297A (en) * | 1996-04-30 | 1997-11-19 | Warner-Lambert Company | Substituted piperazines and piperidines as central nervous system agents |
| WO1997044329A1 (en) * | 1996-05-20 | 1997-11-27 | Teijin Limited | Diarylalkyl cyclic diamine derivatives as chemokine receptor antagonists |
| JP3577183B2 (ja) | 1996-06-17 | 2004-10-13 | 花王株式会社 | 動脈硬化症予防・治療剤 |
| DE19637237A1 (de) * | 1996-09-13 | 1998-03-19 | Merck Patent Gmbh | Piperazin-Derivate |
| JPH10147568A (ja) | 1996-11-19 | 1998-06-02 | Mitsui Chem Inc | ナフタレン誘導体およびそれを有効成分として含有する医薬品 |
| JPH10182550A (ja) | 1996-12-25 | 1998-07-07 | Mitsui Chem Inc | ヒドロキシ安息香酸誘導体およびそれを有効成分として含有する医薬品 |
| JP4139453B2 (ja) | 1997-09-24 | 2008-08-27 | 興和株式会社 | 細胞接着阻害剤 |
| WO1999042446A1 (fr) * | 1998-02-19 | 1999-08-26 | Kowa Co., Ltd. | Composes cycliques d'amide |
| JP2000319277A (ja) | 1999-05-11 | 2000-11-21 | Ono Pharmaceut Co Ltd | 縮合ピラジン化合物およびその化合物を有効成分とする薬剤 |
| US6509329B1 (en) * | 2001-06-29 | 2003-01-21 | Kowa Co., Ltd. | Cyclic diamine compound with 6-membered ring groups |
-
2001
- 2001-06-29 US US09/893,681 patent/US6432957B1/en not_active Expired - Fee Related
-
2002
- 2002-06-27 EP EP02736190A patent/EP1400521B1/en not_active Expired - Lifetime
- 2002-06-27 DE DE60223373T patent/DE60223373T2/de not_active Expired - Lifetime
- 2002-06-27 AT AT02736190T patent/ATE377596T1/de not_active IP Right Cessation
- 2002-06-27 WO PCT/JP2002/006491 patent/WO2003002554A1/ja active IP Right Grant
- 2002-06-27 JP JP2003508935A patent/JP4220897B2/ja not_active Expired - Fee Related
- 2002-06-27 CA CA2451562A patent/CA2451562C/en not_active Expired - Fee Related
- 2002-06-27 ES ES02736190T patent/ES2295350T3/es not_active Expired - Lifetime
- 2002-06-27 CN CNB028128222A patent/CN1309720C/zh not_active Expired - Fee Related
- 2002-06-27 KR KR1020037016481A patent/KR100878416B1/ko not_active IP Right Cessation
- 2002-06-28 TW TW091114338A patent/TWI226240B/zh not_active IP Right Cessation
-
2004
- 2004-08-27 HK HK04106467A patent/HK1065032A1/xx not_active IP Right Cessation
Also Published As
| Publication number | Publication date |
|---|---|
| DE60223373T2 (de) | 2008-02-21 |
| KR20040015739A (ko) | 2004-02-19 |
| CN1309720C (zh) | 2007-04-11 |
| TWI226240B (en) | 2005-01-11 |
| JPWO2003002554A1 (ja) | 2004-10-14 |
| EP1400521A1 (en) | 2004-03-24 |
| EP1400521A4 (en) | 2005-04-06 |
| US6432957B1 (en) | 2002-08-13 |
| CA2451562A1 (en) | 2003-01-09 |
| CN1520408A (zh) | 2004-08-11 |
| CA2451562C (en) | 2010-02-09 |
| WO2003002554A1 (fr) | 2003-01-09 |
| EP1400521B1 (en) | 2007-11-07 |
| DE60223373D1 (de) | 2007-12-20 |
| ATE377596T1 (de) | 2007-11-15 |
| ES2295350T3 (es) | 2008-04-16 |
| JP4220897B2 (ja) | 2009-02-04 |
| KR100878416B1 (ko) | 2009-01-13 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| HK1065032A1 (en) | Piperazine compounds | |
| NZ532494A (en) | Dibenzylamine compound and medicinal use thereof | |
| TW200420542A (en) | A compound having TGF β inhibition activity and a medicinal composition containing the same | |
| JO2311B1 (en) | Alkyl inhibitors Ariel phosphodiesterase-4 | |
| NZ545692A (en) | PPAR-activating compound and pharmaceutical composition containing same | |
| DE60336850D1 (en) | Substituierte arylcyclopropylacetamide als glucokinaseaktivatoren | |
| GB0111523D0 (en) | Chemical compounds | |
| HK1069395A1 (en) | Phthalazinone derivatives 2,3 | |
| NO20050073L (no) | Ringsubstituerte difenylazetidinoner, deres fremstilling, deres anvendelse samt legemidler inneholdende forbindelsene | |
| TW200619212A (en) | Morpholine derivatives | |
| CA2313122A1 (en) | Bicycliccarbonyl indole compounds as anti-inflammatory/analgesic agents | |
| HK1025572A1 (en) | Tricyclic compounds | |
| NZ334976A (en) | Benzonaphthyridine derivatives and their use for treating airway disorders and dermatoses | |
| PH12009500610A1 (en) | 4-imidazolin-2-one compounds | |
| DE60025848D1 (en) | Pyrimidin-derivate als selective inhibitoren von cox-2 | |
| WO2002072009A3 (en) | Heterocyclic derivatives for the treatment of cancer and other proliferative diseases | |
| JO2321B1 (en) | 4-phenyl-pyridine derivatives | |
| ES2187261A1 (es) | Compuestos de eteres y amidas y su preparacion, como agentes anti-diabeticos. | |
| MY138263A (en) | Therapeutic chroman compounds | |
| WO2004030664A3 (en) | New compounds for the inhibition of undesired cell proliferation and use thereof | |
| IL148147A0 (en) | Use of bis-sulfonamides for producing medicaments used for preventing or treating hyperlipidaemia | |
| CA2261271A1 (en) | Dihydrodibenzo[b,e]oxazepine derivatives and pharmaceutical composition containing the same | |
| ATE293961T1 (de) | Verwendung von hydantoin und seinen derivaten gegen hypalbuminämie | |
| HUP9802348A2 (hu) | 2-Fenil-3-aroil-benzotiofének alkalmazása plazminogén aktivátor inhibitor-1 gátló hatású gyógyszerkészítmények előállítására | |
| ES2102295A1 (es) | Nuevos compuestos derivados de la n-benzoilmetil-piperidina. |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PC | Patent ceased (i.e. patent has lapsed due to the failure to pay the renewal fee) |
Effective date: 20120627 |